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VALORISATION: IMPLICATION FOR FUTURE RESEARCH AND PRACTICE 
In this section, I consider possible implications, both for the theoretical development of 
research on quality of TB diagnostic care and the specific public policy implications for 
professional practice in patients with suspected TB in resource poor setting. The find-
ings in this study suggest a number of avenues for further research. Firstly, I recognize 
that by situating this research in Ethiopia context, the generalizability of my findings 
outside the resource constrained setting is limited. Although recent WHO report and 
others have shown that clinicians often deviate from internationally recommended TB 
management, our ﬁndings add that care oﬀered to smear-negative cases continues to 
be deviant from the standards, compared to smear-positive TB cases. This then raises 
the question of the perceived habitual bias by TB healthcare providers, who apparently 
still consider managing smear-positive cases to be the most eﬀective strategy to curb 
the TB epidemic. This treatment adherence gap would be signiﬁcantly closed if strate-
gies that increase compliance to ISTC are identiﬁed by programme managers and poli-
cymakers in hospitals that best meet the desired standards. Therefore, we suggest that 
future quality improvement initiatives should focus on the role for real-time, clinic-level 
monitoring of smear negative TB suspect evaluation practices, in order to capture indi-
vidual data on clinical measures related to care of smear-negative TB from every patient 
evaluated. 
Less well understood are the determinants of provider adherence to TB treatment 
guidelines. In particular, there is increasing recognition that guideline implementation is 
heavily dependent on provider behaviour and in order to improve the quality of diag-
nostic care, understanding and subsequently changing provider behaviour is required. 
Our findings indicate that the degree of trust that TB service providers had in the diag-
nostic test results had a great impact on compliance with the guidelines. Thus, address-
ing their negative perception of sputum smear microscopy may be just as important as 
scaling up the diagnostic test. Furthermore, there was dilemma among TB service pro-
viders about relying only on sputum microscopy in passive case finding. The underlying 
conflict was a lack of alternative diagnostic modalities when the initial test result does 
not correspond with the patient’s clinical presentation. A better strategy to retest those 
patients whose initial tests are negative in settings where TB is frequently missed may 
improve compliance with the guideline.  
A recent review of the TB guidelines showed that the overall methodological quality 
of the guideline was low. Several domains of the guidelines, such as applicability to 
specific local situations, contributed to their poor performance. Our findings offer real-
life examples of what is needed to customize TB guidelines to local contexts of 
healthcare in order to improve compliance. We recommend, more studies in other 
regions and across a wider health facility spectrum to generalize a whole picture of non-
adherence in Ethiopia and develop appropriate strategies that influence their compli-
ance with the guidelines. With the important limitation of this study described above in 
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mind, further studies are now needed to develop appropriate interventions aimed at 
addressing the critical factors suggested by this study, and to test these systematically. 
Consideration should be given to specific sub-groups (smear and culture negative TB 
suspects) as an important influence on guideline compliance. 
Numerous decisions are made by care providers, on the basis of an estimated prob-
ability that a speciﬁc disease or condition is present in an individual. In the diagnostic 
setting, the probability estimates are commonly based on combining information from 
multiple predictors observed or measured from an individual. While application of pre-
dictive modelling in patients with clinical suspicion of TB has been described before, 
these studies usually combined only independent significant predictive variables into 
the decision models. In addition, information from a single predictor is often insufﬁcient 
to provide reliable estimates of diagnostic probabilities or risks. However, in this study 
the critical question is whether patients with smear and culture negative result can be 
detected and treated early by predictive model. Our finding is in agreement with a pre-
vious study that reported that predictive models based on clinical variables may not be 
useful to discriminate culture-negative TB, because of the variable presentations of 
symptoms. Therefore, screening for active TB is one of several possible interventions 
that can improve early detection of all forms of TB, but providing better access to diag-
nostic tests that are more sensitive than smear microscopy is the first essential step. In 
addition, sound training in threshold principles and providing tools to correctly assess 
patients with smear and culture negative results might help in making a better diagnos-
tic decision in resource poor settings.  
There is an absolute need to find biomarkers that can distinguish between individu-
als infected having the highest risk of developing TB (susceptibility) and those who have 
the highest probability of resisting development of the disease (protection). This would 
significantly help the control programme to break the chain of transmission of the dis-
ease in the long run. We are also in need of validated biomarkers that can be translated 
as point-of-care assays for early diagnosis and treatment of active TB patients in high-
incidence countries. The results of our findings support our hypothesis that, patients 
unable to respond with an effective production of salivary NO metabolites in response 
to Mtb infection, are more likely to be associated with increased risk of acquiring TB. 
Our findings and previous studies suggest that the use of NO metabolites as a bi-
omarker may have great value for screening of smear positive TB. Will it be possible to 
learn from this naturally induced host response and better understand those mecha-
nisms that control infection and exploit their value as potential indicators of protection? 
There are many studies that suggest that the magnitude of the immune response re-
flects the magnitude of the bacterial load and two longitudinal studies in untreated 
contacts suggest that the highest responders are at greatly elevated risk of TB, but 
these studies are relatively small and lack detailed sequential testing routines. Thus the 
kinetics and duration of the differences are unknown; however, the fact that the two 
studies produced similar results in very different populations and environments (Ethio-
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pia and Germany) is encouraging. Studies to address the questions of remote versus 
recent infection, predictive value and optimization of the assays, and their usefulness in 
HIV infected patients should prove very valuable. 
  
